Literature DB >> 17855352

Dynamic interaction between Src and C-terminal Src kinase in integrin alphaIIbbeta3-mediated signaling to the cytoskeleton.

Martin Vielreicher1, Gregory Harms2, Elke Butt3, Ulrich Walter4, Achim Obergfell3.   

Abstract

Integrin-bound Src tyrosine kinase mediates alpha(IIb)beta(3) out-side-in signaling to the cytoskeleton required for platelet adhesion and thrombus formation. Src activation (signal initiation) by phosphorylation of Tyr-418 occurs at lamellipodia leading edges. However, little is known about Src inactivation mediated by C-terminal Src kinase (Csk) Tyr-529 phosphorylation. In an established platelet model cell line (A5-Chinese hamster ovary), we studied the inactivation of Src during alpha(IIb)beta(3)-mediated adhesion to fibrinogen with live cell fluorescence resonance energy transfer (FRET) microscopy. Imaging revealed highly dynamic Src-Csk interactions at the leading edges of active lamellipodia. The Src-Csk interaction followed a highly dynamic pattern. Every 2-3 min, Src-Csk complexes moved inward in the cell, reorganized, and formed stable focal adhesions. These accumulations were primarily seen during retraction of lamellipodia, whereas no interaction was observed during protrusions. Western blot analysis during the run time of FRET signaling revealed an increase in Csk-mediated SrcTyr-529 phosphorylation with a parallel decline of tyrosine 418 phosphorylation. Mutation analysis provided additional insights into the role of Src. Although inactivation of Csk (CskK222R) had no effect on cell adhesion and spreading efficiency, cells with constitutively active expressed Src (SrcY529F) exhibited hardly any adhesion and no spreading. The few adherent cells showed weak focal adhesions that were disorganized and oversized. The data clearly demonstrate the important role of tight Src control by Csk for functional cell adhesion and spreading. The novel experimental FRET approach reported here for the inactivation of Src can be readily applied to other integrin and signaling pathways, including closely related Src family kinase members.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17855352     DOI: 10.1074/jbc.M704107200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  5 in total

1.  Expression of typical osteoclast markers by PBMCs after PEG-induced fusion as a model for studying osteoclast differentiation.

Authors:  Luz M Castillo; Carlos A Guerrero; Orlando Acosta
Journal:  J Mol Histol       Date:  2017-03-25       Impact factor: 2.611

2.  Pro32Pro33 mutations in the integrin β3 PSI domain result in αIIbβ3 priming and enhanced adhesion: reversal of the hypercoagulability phenotype by the Src inhibitor SKI-606.

Authors:  Kendra H Oliver; Tammy Jessen; Emily L Crawford; Chang Y Chung; James S Sutcliffe; Ana M Carneiro
Journal:  Mol Pharmacol       Date:  2014-04-02       Impact factor: 4.436

3.  Regulation of the prometastatic neuregulin-MMP13 axis by SRC family kinases: therapeutic implications.

Authors:  Ana Orive-Ramos; Samuel Seoane; Alberto Ocaña; Atanasio Pandiella; Juan Carlos Montero
Journal:  Mol Oncol       Date:  2017-10-31       Impact factor: 6.603

4.  An integrin-contactin complex regulates CNS myelination by differential Fyn phosphorylation.

Authors:  Lisbeth Schmidt Laursen; Colin W Chan; Charles ffrench-Constant
Journal:  J Neurosci       Date:  2009-07-22       Impact factor: 6.167

5.  Enzymatic detachment of therapeutic mesenchymal stromal cells grown on glass carriers in a bioreactor.

Authors:  Denise Salzig; Alexandra Schmiermund; Pablo P Grace; Christiane Elseberg; Christian Weber; Peter Czermak
Journal:  Open Biomed Eng J       Date:  2013-12-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.